Results 251 to 254 of about 17,710 (254)

Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis

Journal of Allergy and Clinical Immunology, 2019
Robert Bissonnette, Benjamin Ungar, Mayte Suarez-Farinas   +2 more
exaly  

Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age

New England Journal of Medicine
Matthew F Wipperman
exaly  

Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation

New England Journal of Medicine
Alberto A Papi
exaly  

FDA approves dupilumab for severe eczema

Nature Reviews Drug Discovery, 2017
exaly